EPA Approves PDI’s Sani-Prime® Germicidal Spray for Use Against SARS-CoV-2
The EPA has approved PDI’s claim that Sani-Prime® Germicidal Spray is effective against SARS-CoV-2, the virus that causes COVID-19.
The EPA approval expanded the label claims for Sani-Prime Germicidal Spray (EPA Reg No. 9480-10) to include deactivation of SARS-CoV-2, the virus that causes COVID-19, after one minute of contact time on hard, nonporous surfaces. Before a product can legally make efficacy claims against a particular pathogen, the claim must be approved by the EPA based on a thorough review of scientific data. According to the data provided by PDI Healthcare, the Sani-Prime Germicidal Spray caused a 3-log reduction against the SARS-CoV-2 virus, which meets the EPA’s efficacy requirements. Prior to receiving approval for this claim, Sani-Prime Germicidal Spray was included on EPA’s List N: Disinfectants for Coronavirus (COVID-19).
Microbac Lab tested the spray in compliance with EPA Product Performance Test Guideline OCSPP 810.2200: Disinfectants for Use on Environmental Surfaces, Guidance for Efficacy Testing. When performing the testing, the lab applied the virus to a surface and let it dry. They then applied the spray to the surface, recovered what was left on the surface and applied it to cell cultures. They were then able to tell how effective the spray was at deactivating the virus based on how many viable cells remained.
To learn more about PDI’s other disinfectant products currently being tested against the SARS-CoV-2 virus, click here.